Broadway Financial Restates Q1, Cites Loan Accounting Errors & Widens Loss

Ticker: BYFC · Form: 10-Q/A · Filed: Dec 31, 2025 · CIK: 1001171

Sentiment: bearish

Topics: Restatement, Financial Reporting Error, Internal Controls, Loan Accounting, Credit Losses, Operational Risk, Banking Sector, SEC Filing

Related Tickers: BYFC

TL;DR

**BYFC's restatement and widened loss signal deeper control issues and potential asset quality concerns; steer clear until remediation is proven effective.**

AI Summary

BROADWAY FINANCIAL CORP filed a 10-Q/A to restate its Q1 2025 financial statements due to errors in loan participation agreements and an unconsidered appraisal. The restatement significantly increased 'Loans Receivable Held for Investment' by $21.8 million and recorded a 'Secured Borrowing' for the same amount as of March 31, 2025. Interest and fees on loans receivable increased by $427 thousand for Q1 2025 and $415 thousand for Q1 2024. The Allowance for Credit Losses (ACL) saw a $1.2 million increase for Q1 2025 and a $13 thousand decrease for Q1 2024. Net loss attributable to common stockholders for Q1 2025 widened to $(3.439) million from $(0.154) million in Q1 2024, primarily due to a $1.914 million provision for credit losses in Q1 2025 compared to $247 thousand in Q1 2024, and a $1.943 million operational loss in Q1 2025. Total assets decreased from $1,334.883 million at December 31, 2024, to $1,258.776 million at March 31, 2025, while total liabilities decreased from $1,049.691 million to $974.994 million over the same period. The company also reported material weaknesses in internal control over financial reporting.

Why It Matters

This restatement by BROADWAY FINANCIAL CORP is critical for investors as it reveals material weaknesses in internal controls, casting doubt on the reliability of previously reported financials. The significant increase in the provision for credit losses to $1.914 million and the $1.943 million operational loss for Q1 2025, coupled with the restatement of loan participation agreements, could signal underlying asset quality issues or inadequate risk management. This could erode investor confidence, impact the company's competitive standing against more stable regional banks, and potentially affect its ability to attract capital or maintain favorable borrowing terms. Employees and customers might also perceive increased instability, potentially leading to talent retention challenges or deposit outflows.

Risk Assessment

Risk Level: high — The risk level is high due to the restatement of financial statements for Q1 2025, indicating material weaknesses in internal control over financial reporting. Specifically, the company identified errors related to loan participation agreements and an unconsidered appraisal for a collateral-dependent loan, leading to a $21.8 million increase in 'Loans Receivable Held for Investment' and a corresponding 'Secured Borrowing' liability. This, combined with a significant increase in the provision for credit losses to $1.914 million for Q1 2025 and a $1.943 million operational loss, suggests substantial control deficiencies and potential asset quality deterioration.

Analyst Insight

Investors should exercise extreme caution and consider holding off on new investments in BYFC until the company demonstrates successful remediation of its material weaknesses in internal control over financial reporting. Current shareholders should closely monitor the effectiveness of the stated remediation plan and any further disclosures regarding asset quality or operational losses, as the restatement indicates significant financial reporting risks.

Financial Highlights

total Assets
$1,258,776,000
net Income
-$3,439,000
cash Position
$15,794,000

Key Numbers

Key Players & Entities

FAQ

Why did Broadway Financial Corp restate its Q1 2025 financial statements?

Broadway Financial Corp restated its Q1 2025 financial statements due to an error related to certain loan participation agreements that did not meet sales accounting requirements, and the failure to consider an appraisal for a collateral-dependent loan when estimating expected credit losses.

What was the impact of the restatement on Broadway Financial Corp's loans receivable?

The restatement resulted in an increase of 'Loans Receivable Held for Investment' by $21.8 million as of March 31, 2025, because the transferred interests were reclassified as secured borrowing arrangements instead of sales.

How did the restatement affect Broadway Financial Corp's net income for Q1 2025?

The restatement, combined with other adjustments, led to a net loss attributable to common stockholders of $(3.439) million for the three months ended March 31, 2025, significantly wider than the $(0.154) million loss in the prior year.

What were the key changes in Broadway Financial Corp's interest income and expense due to the restatement?

Interest and fees on loans receivable increased by $427 thousand for Q1 2025 and $415 thousand for Q1 2024, while interest on borrowings also increased by the same amounts, reflecting the reclassification of loan participation agreements as secured borrowings.

Did Broadway Financial Corp identify any internal control weaknesses?

Yes, management identified material weaknesses in Broadway Financial Corp's internal control over financial reporting, leading to the conclusion that disclosure controls and procedures were not effective as of March 31, 2025.

What was Broadway Financial Corp's provision for credit losses in Q1 2025?

Broadway Financial Corp's provision for credit losses for the three months ended March 31, 2025, was $1.914 million, a substantial increase compared to $247 thousand for the same period in 2024.

What is Broadway Financial Corp's plan to address the identified material weaknesses?

Broadway Financial Corp's management has taken and is taking additional steps, as described under 'Remediation Plan' in Part I, Item 4 of the Form 10-Q/A, to remediate these material weaknesses in internal control over financial reporting.

How much was the operational loss for Broadway Financial Corp in Q1 2025?

Broadway Financial Corp reported an operational loss of $1.943 million for the three months ended March 31, 2025, which was not present in the comparable period of 2024.

What should investors know about relying on previous Broadway Financial Corp reports?

Investors should rely only on the financial information and other disclosures regarding the Restated Period contained in this Form 10-Q/A, and not on any previously filed reports, earnings releases, or similar communications relating to such period.

What is the primary business of Broadway Financial Corp?

Broadway Financial Corp operates one reportable segment, banking, through its wholly owned subsidiary, City First Bank, National Association, offering various banking products and services.

Risk Factors

Industry Context

Broadway Financial Corp operates in the banking sector, which is characterized by intense competition, stringent regulatory oversight, and sensitivity to interest rate fluctuations. The industry is undergoing digital transformation, with a growing emphasis on fintech solutions and customer experience. Consolidation is also a trend, as smaller institutions face challenges in scale and technological investment.

Regulatory Implications

The identification of material weaknesses in internal control over financial reporting by Broadway Financial Corp could attract increased scrutiny from regulators like the SEC and the Federal Reserve. This may lead to more rigorous compliance requirements, potential fines, or mandated remediation plans, impacting operational efficiency and investor confidence.

What Investors Should Do

  1. Monitor the company's remediation efforts for identified material weaknesses in internal control. The effectiveness of these efforts will be crucial for restoring investor confidence in financial reporting accuracy.
  2. Closely analyze the impact of the restatement on the company's loan portfolio quality and future credit loss expectations. The $1.2 million increase in ACL and the $1.914 million provision for credit losses warrant careful review.
  3. Evaluate the sustainability of the company's operational performance. The $1.943 million operational loss in Q1 2025, alongside the wider net loss, requires understanding the underlying causes and management's strategy for improvement.
  4. Assess the company's capital adequacy and liquidity position in light of the reduced asset base and the increased borrowing. The decrease in total assets to $1,258.776 million and liabilities to $974.994 million needs to be understood in the context of strategic goals.

Key Dates

Glossary

Allowance for Credit Losses (ACL)
An estimate of the amount of loans that are expected to be uncollectible. It is a contra-asset account that reduces the carrying value of loans on the balance sheet. (The ACL increased by $1.2 million for Q1 2025 due to the restatement, indicating a higher expected loss on the loan portfolio.)
Loans Receivable Held for Investment
Loans that a financial institution intends to hold until maturity, generating interest income and principal repayment. (This category saw a $21.8 million increase due to the restatement, impacting the company's asset base and revenue recognition.)
Secured Borrowing
A loan that is backed by collateral, meaning the lender has a claim on specific assets if the borrower defaults. (A secured borrowing of $21.8 million was recorded as of March 31, 2025, corresponding to the increase in loans receivable, likely related to the loan participation agreements.)
Provision for Credit Losses
An expense recognized in the income statement to account for the estimated losses on loans and other credit exposures. (This provision increased substantially to $1.914 million in Q1 2025 from $247 thousand in Q1 2024, significantly contributing to the wider net loss.)
Material Weaknesses
A deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. (The identification of material weaknesses in internal control over financial reporting is a significant concern for investors regarding the accuracy and reliability of the company's financial disclosures.)

Year-Over-Year Comparison

Compared to the previous filing period (likely Q4 2024 or prior year's Q1), Broadway Financial Corp's Q1 2025 results show a significant deterioration. The restatement led to a substantial increase in 'Loans Receivable Held for Investment' and a corresponding 'Secured Borrowing.' Most critically, the net loss widened dramatically to $(3.439) million from $(0.154) million, driven by a much larger provision for credit losses and an operational loss. Total assets and liabilities also decreased, indicating a contraction in the balance sheet.

Filing Stats: 4,598 words · 18 min read · ~15 pages · Grade level 19.5 · Accepted 2025-12-31 11:01:05

Key Financial Figures

Filing Documents

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS Item 1. Consolidated Financial Statements (Unaudited) Consolidated Statements of Financial Condition as of March 31, 2025 and December 31, 2024 2 Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024 3 Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024 4 Consolidated Statements of Changes in Stockholders' Equity for the three months ended March 31, 2025 and 2024 5 Notes to Unaudited Consolidated Financial Statements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 37 Item 4.

Controls and Procedures

Controls and Procedures 37 PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 38 Item 1A.

Risk Factors

Risk Factors 38 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 3. Defaults Upon Senior Securities 39 Item 4. Mine Safety Disclosures 39 Item 5. Other Information 39 Item 6. Exhibits 39

Signatures

Signatures 40 EXPLANATORY NOTE Broadway Financial Corporation (the "Company") is filing this Amendment No. 1 on Form 10-Q/A (this "Form 10-Q/A") to amend and restate certain information included in the Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed with the Securities and Exchange Commission ("SEC") on July 24, 2025 (the "Original Form 10-Q"). As disclosed in the Company's Current Report on Form 8-K filed with the SEC on October 17, 2025, the Audit Committee of the Board of Directors of the Company, the holding company of City First Bank, National Association ("City First Bank"), based on consultations with the Company's management, concluded that the Company's unaudited interim consolidated financial statements for the quarter ended March 31, 2025 (the "Restated Period"), as previously filed with the SEC, should no longer be relied upon because of an error related to certain loan participation agreements and should therefore be restated. Specifically, the Company determined that several loan participation agreements originated by City First Bank and sold to other financial institutions did not meet the requirements in Accounting Standards Codification Topic 860 to be treated as sales for accounting purposes, and therefore should have been recorded as secured borrowing arrangements. In addition, subsequent to the filing of the Original Form 10-Q, management discovered that an appraisal had been received for a loan that was considered to be collateral dependent prior to the date that the financial statements for the quarter ended March 31, 2025, were available to be issued. This appraisal had not been considered when estimating the amount of expected credit losses for this particular loan as of March 31, 2025. The related adjustment to the consolidated statements of financial condition for treating such transferred interests as secured borrowing arrangements as of March 31, 2025, is to increase "Loans Receivable Held

, Item 1. Financial Statements

Part I, Item 1. Financial Statements

, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

, Item 4. Controls and Procedures

Part I, Item 4. Controls and Procedures

, Item 1A. Risk Factors

Part II, Item 1A. Risk Factors The exhibit list included in Part II, Item 6 "Exhibits" herein has been amended to contain currently dated certifications from the Company's Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. In accordance with applicable SEC rules, this Form 10-Q/A also includes an updated signature page. Except as expressly provided herein, this Form 10-Q/A speaks only as of the date the Original Form 10-Q was filed, and we have not undertaken herein to amend, supplement or update any information contained in the Original Form 10-Q to give effect to any subsequent events. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events, results or developments that occurred or facts that became known to us after the date of the Original Form 10-Q. Accordingly, this Form 10-Q/A should be read in conjunction with our filings made with the SEC subsequent to the filing of the Original Form 10-Q. Internal Control Considerations In connection with the restatements noted above, management has reassessed the effectiveness of our disclosure controls and procedures and has included applicable disclosures in Part I, Item 4 of this Form 10-Q/A, "Controls and Procedures." Management identified material weaknesses in our internal control over financial reporting as described under "Evaluation of Disclosure Controls and Procedures" in Part I, Item 4 of this Form 10-Q/A, resulting in the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures and internal control over financial reporting were not effective as of March 31, 2025. Management has taken and is taking additional steps, as described under "Remediation Plan" in Part I, Item 4 of this Form 10-Q/A, to remediate these material weaknesses in our internal control over financial reporting. 1 Table of Contents BROADWAY FINAN

View Full Filing

View this 10-Q/A filing on SEC EDGAR

View on Read The Filing